Wednesday, August 19, 2026

Boryung Begins First Global CDMO Supply of Alimta Through Taiwan Partnership

Boryung Pharmaceutical starts supplying Alimta to Lotus, enhancing global CDMO efforts and addressing chemotherapy drug shortages.

World Bank Lowers Global Growth Forecast to 2.5%: What This Means for Asia in 2026

The World Bank projects global growth at 2.5% for 2023, citing energy prices and inflation from Middle East conflicts as key factors.

Unlocking AI: How SK Telecom’s New 100MW Data Center is Revolutionizing the Industry

SK Telecom's CTO highlights AI data centers as vital infrastructure, emphasizing rapid transformations in energy and server architectures.

Tag: Matica Biotechnologies

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Matica Biotechnologies Signs Adenovirus Therapy CDMO Deal With North American Research Institution

CHA Biotech's U.S. subsidiary, Matica Biotechnologies, secures a CDMO agreement for adenovirus therapy with a major North American institution.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.